This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H7N2 Hemagglutinin (HA), C-His
Product Overview
BioVenic's Recombinant Influenza A H7N2 Hemagglutinin (HA), C-His is a recombinant protein expressed from Baculovirus-insect cell. Its predicted molecular weight is 57.7 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
H7 viruses have the potential to infect mammals beyond humans. For instance, in the United States, H7N7 influenza viruses were isolated from a seal in 1980, and H7N2 viruses were identified in cats in 2016. In South Korea, H7N2 viruses were detected in pigs in 2001. The hemagglutinin (HA) protein, a homotrimeric glycoprotein on the surface of influenza viruses, is vital for the virus's ability to infect host organisms.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Lyashko, Aleksandr V et al. "Antigenic Architecture of the H7N2 Influenza Virus Hemagglutinin Belonging to the North American Lineage." International journal of molecular sciences vol. 25,1 212. 22 Dec. 2023